Core Viewpoint - Morgan Stanley's report indicates that MicroPort Scientific Corporation (02252) has shown stronger-than-expected order trends in the first half of the year, reflecting a structural shift in the company's growth and profitability drivers [1] Financial Performance - The company reported a 77% year-on-year increase in revenue, with a 59% reduction in net loss [1] - Overseas sales surged by 189%, accounting for 58% of total revenue, highlighting the significance of international business as a core growth engine [1] Management Guidance - Management aims for approximately 85% revenue growth for the year and further reduction in net loss [1] - The company plans to strictly control capital expenditures between 5 million to 10 million RMB, targeting free cash outflow to be less than 200 million RMB [1] Analyst Rating and Target Price - Morgan Stanley raised the target price from HKD 19.1 to HKD 30.9 and upgraded the rating from "Neutral" to "Overweight" [1]